Hello, everyone, and how are you this fine morning? A warm and shiny sun is enveloping the peacefully quiet Pharmalot campus, where we have only the official mascot to keep us company. And since our pooch spends most of the day snoozing, we have fewer distractions as we forage for interesting items. Moments to cherish, yes? On that note, we happily offer the latest menu of tidbits to help you on your journey today. Hope all goes well and you conquer the world. And as always, we invite you to keep in touch. We accept tips and dossiers. …

In an unusual move, House Republicans are warning drug makers against complying with a House investigation into drug prices, BuzzFeed News reports. Republicans on the House Oversight Committee sent letters to a dozen chief executives, warning that information they provide to the committee could be leaked to the public by Democratic chair Elijah Cummings in an effort to tank their stock prices. Politicians routinely spar over committee work, but Democrats say warning companies not to comply with an investigation is unconventional — perhaps unprecedented.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy